clenbuterol has been researched along with Cardiac Remodeling, Ventricular in 6 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clenbuterol treatment improved in vivo LV function measured with echocardiography (LVEF (%): HF 35." | 5.35 | Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure. ( Barton, PJ; Felkin, LE; Lee, J; Siedlecka, U; Soppa, GK; Stagg, MA; Terracciano, CM; Yacoub, MH; Youssef, S, 2008) |
| "Clenbuterol (Cl), a β2 agonist, is associated with enhanced myocardial recovery during left ventricular assist device (LVAD) support, and exerts beneficial remodelling effects during mechanical unloading (MU) in rodent heart failure (HF)." | 3.80 | Impact of combined clenbuterol and metoprolol therapy on reverse remodelling during mechanical unloading. ( Gandhi, A; Ibrahim, M; Kukadia, P; Navaratnarajah, M; Shah, A; Siedlecka, U; Soppa, G; Terracciano, CM; van Doorn, C; Yacoub, MH, 2014) |
| "Heart failure is a widespread condition in the United States that is predicted to significantly increase in prevalence in the next decade." | 2.61 | Left ventricular assist device recovery: does duration of mechanical support matter? ( Chaparro, SV; Pham, BN, 2019) |
| "Clenbuterol has recently been shown to reverse pathologic cardiac remodeling during left ventricular assist device (LVAD) support, leading to restored ventricular function and explantation of LVAD devices." | 1.35 | Effect of clenbuterol administration on the healthy murine heart. ( Anderson, M; Larson, D; Moore, D, 2008) |
| "Clenbuterol treatment improved in vivo LV function measured with echocardiography (LVEF (%): HF 35." | 1.35 | Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure. ( Barton, PJ; Felkin, LE; Lee, J; Siedlecka, U; Soppa, GK; Stagg, MA; Terracciano, CM; Yacoub, MH; Youssef, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pham, BN | 1 |
| Chaparro, SV | 1 |
| Navaratnarajah, M | 1 |
| Siedlecka, U | 2 |
| Ibrahim, M | 1 |
| van Doorn, C | 1 |
| Soppa, G | 1 |
| Gandhi, A | 1 |
| Shah, A | 1 |
| Kukadia, P | 1 |
| Yacoub, MH | 3 |
| Terracciano, CM | 2 |
| Moore, D | 1 |
| Anderson, M | 1 |
| Larson, D | 1 |
| Barton, PJ | 2 |
| Felkin, LE | 2 |
| Birks, EJ | 1 |
| Cullen, ME | 1 |
| Banner, NR | 1 |
| Grindle, S | 1 |
| Hall, JL | 1 |
| Miller, LW | 1 |
| Soppa, GK | 1 |
| Lee, J | 1 |
| Stagg, MA | 1 |
| Youssef, S | 1 |
| Sleeper, MM | 1 |
| Kearns, CF | 1 |
| McKeever, KH | 1 |
1 review available for clenbuterol and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Left ventricular assist device recovery: does duration of mechanical support matter?
Topics: Adult; Atrophy; Calcium; Cardiomyopathy, Dilated; Clenbuterol; Female; Heart; Heart Failure; Heart T | 2019 |
5 other studies available for clenbuterol and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Impact of combined clenbuterol and metoprolol therapy on reverse remodelling during mechanical unloading.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Animals; Calcium; Clenb | 2014 |
Effect of clenbuterol administration on the healthy murine heart.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Collagen; Echocardiography; Extracellular Matrix; Fe | 2008 |
Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Cardiomyopathy, Dilated; Chemokine CX | 2005 |
Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure.
Topics: Actin Cytoskeleton; Action Potentials; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists | 2008 |
Chronic clenbuterol administration negatively alters cardiac function.
Topics: Adrenergic beta-Agonists; Animals; Aorta, Thoracic; Clenbuterol; Echocardiography, Stress; Female; H | 2002 |